Omni Bridgeway backs Allergan breast implant class action

Omni Bridgeway is funding a class action brought by William Roberts Lawyers against Allergan Inc, Allergan Limited and Allergan Australia Pty Ltd, a global pharmaceutical company that manufactures breast implants and tissue expanders, on behalf of consumers who had a Natrelle Biocell macro-textured breast implant or Natrelle Biocell tissue expander implanted in them in Australia from 1 January 2011.

In July 2019, Allergan announced that it had decided to voluntarily recall the implants on a worldwide basis because of increasing evidence of an association between macro-textured breast implants and the development of breast implant-associated anaplastic large cell lymphoma.

The claim will allege that the implants were not of acceptable quality in breach of section 54 of the Australian Consumer Law, and that Allergan is liable to compensate affected consumers for loss and damage caused by the breach.

Read more.